News on technologies and applications for point-of-care testing.
The company's revenues were driven by its centralized and point-of-care solutions as well as its molecular diagnostics business, both rising in the single digits.
Within Diagnostics, year-over-year core laboratory Q3 revenues rose 8 percent to $1.18 billion but molecular diagnostics revenues fell 8 percent to $111 million.
Investigators at the Foundation for Research and Technology - Hellas, a Greek research institute, are coordinating the effort.
The director of the Biomedical Advanced Research and Development Authority has launched two new funding programs in the past three years.
The Broad Institute spinout will develop its CRISPR-based Sherlock platform for battlefield-ready diagnostics for infectious disease agents.
